Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells

Cellular and Molecular Neurobiology

Volumn 17, Issue 5, 1997, Pages 483-493

  Stark, Sheryl ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Aminoalklindoles; Anandamide; Cannabinoid receptors; Neuroblastoma cells; 9 tetrahydrocannabinol

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; INDOLE DERIVATIVE; LEVONANTRADOL; UNCLASSIFIED DRUG; WIN 55225; WIN 55365;

ANIMAL CELL; ARTICLE; BINDING SITE; CEREBELLUM; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; GLIOMA CELL; MALE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; BINDING, COMPETITIVE; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CEREBELLUM; CYCLOHEXANOLS; GLIOMA; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYBRID CELLS; MALE; MEMBRANE PROTEINS; MORPHOLINES; NAPHTHALENES; NEUROBLASTOMA; POLYUNSATURATED ALKAMIDES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SENSITIVITY AND SPECIFICITY; TRITIUM;

EID: 0030803804     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026306804802     Document Type: Article

References (11)

1. Bradford, M. M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-4002.
3. Childers, S. R. (1991). Opioid receptor-coupled second messengers. Life Sci. 48:1991-2003.
4. Childers, S. R., Sexton, T., and Roy, M. B. (1994). Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47:711-715.
5. B binding sites in rat central nervous system: A quantitative autoradiographic study. Neuroscience 34:341-357.
6. Compton, D., Johnson, M R., Melvin, L., and Martin, B. R. (1992). Pharmacological profile of a series of bicyclic cannabinoid analogues: Classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260:201-209.
7. Creese, I., and Snyder, S. H. (1975). Receptor binding and pharmacological activity of opiates in the guinea pig intestine. J. Pharmacol. Exp. Ther. 194:205-219.
8. Devane, W. A., Dysarz, F. A. I., Johnson, M. R., Melvin, L. S., and Hewlett, A. C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:605-613.
9. Fan, F., Tao, Q., Abood, M. E., and Martin, B. R. (1996). Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706:13-20.
10. Gaoni, Y., and Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Sco. 86:1646-1647.
11. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., De Costa, B. R., and Rice, K. C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87:1932-1936.